- Home
- DERM vs MAV Comparison
DERM vs MAV Comparison
Compare DERM & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- MAV
- Stock Information
- Founded
- DERM 2014
- MAV 2003
- Country
- DERM United States
- MAV United States
- Employees
- DERM N/A
- MAV N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- MAV Finance Companies
- Sector
- DERM Health Care
- MAV Finance
- Exchange
- DERM Nasdaq
- MAV Nasdaq
- Market Cap
- DERM 181.0M
- MAV 198.7M
- IPO Year
- DERM 2021
- MAV N/A
- Fundamental
- Price
- DERM $7.15
- MAV $8.28
- Analyst Decision
- DERM Strong Buy
- MAV
- Analyst Count
- DERM 1
- MAV 0
- Target Price
- DERM $9.00
- MAV N/A
- AVG Volume (30 Days)
- DERM 179.1K
- MAV 66.2K
- Earning Date
- DERM 08-11-2025
- MAV 01-01-0001
- Dividend Yield
- DERM N/A
- MAV 4.30%
- EPS Growth
- DERM N/A
- MAV N/A
- EPS
- DERM N/A
- MAV N/A
- Revenue
- DERM $56,243,000.00
- MAV N/A
- Revenue This Year
- DERM $28.99
- MAV N/A
- Revenue Next Year
- DERM $52.61
- MAV N/A
- P/E Ratio
- DERM N/A
- MAV N/A
- Revenue Growth
- DERM N/A
- MAV N/A
- 52 Week Low
- DERM $3.54
- MAV $6.37
- 52 Week High
- DERM $8.25
- MAV $8.34
- Technical
- Relative Strength Index (RSI)
- DERM 53.22
- MAV 54.37
- Support Level
- DERM $6.78
- MAV $8.29
- Resistance Level
- DERM $7.34
- MAV $8.36
- Average True Range (ATR)
- DERM 0.35
- MAV 0.05
- MACD
- DERM 0.03
- MAV 0.00
- Stochastic Oscillator
- DERM 78.81
- MAV 67.33
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax, and as a secondary objective, to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.